All Pharma News
Recce Safety Committee Clears 4,000mg Dose in Ph1/2 UTI/Urosepsis

Recce Safety Committee Clears 4,000mg Dose in Ph1/2 UTI/Urosepsis
GLOBENEWSWIRE
30 Apr 2024
Share Share
Recce Completes 5,000 GMP Doses of RECCE® 327 Weekly

Recce Completes 5,000 GMP Doses of RECCE® 327 Weekly
GLOBENEWSWIRE
17 Apr 2024
Share Share
Recce Pharmaceuticals Completes R327 Batch Under GMP

Recce Pharmaceuticals Completes R327 Batch Under GMP
BIOSPACE
17 Apr 2024
Share Share
Recce Pharmaceuticals Provides Business Update

Recce Pharmaceuticals Provides Business Update
GLOBENEWSWIRE
10 Apr 2024
Share Share
Recce Pharma Chosen by UK Govt Innovation Agency for AMR Mission 2024

Recce Pharma Chosen by UK Govt Innovation Agency for AMR Mission 2024
GLOBENEWSWIRE
09 Apr 2024
Share Share
Recce Pharmaceuticals Granted New Patent in Israel for RECCE® Anti-Infectives

Recce Pharmaceuticals Granted New Patent in Israel for RECCE® Anti-Infectives
GLOBENEWSWIRE
04 Apr 2024
Share Share
Recce Announces RECCE® Trademark Registered in Canada, Global IP Portfolio

Recce Announces RECCE® Trademark Registered in Canada, Global IP Portfolio
GLOBENEWSWIRE
22 Mar 2024
Share Share
Recce Completes Dosing Cohort in Phase I/II Trial of RECCE® 327

Recce Completes Dosing Cohort in Phase I/II Trial of RECCE® 327
GLOBENEWSWIRE
19 Mar 2024
Share Share
Recce Pharmaceuticals Doses Next Cohort in Phase I/II Trial of RECCE® 327

Recce Pharmaceuticals Doses Next Cohort in Phase I/II Trial of RECCE® 327
GLOBENEWSWIRE
14 Mar 2024
Share Share
Recce Pharmaceuticals to Present at the ASCPT 2024 Annual Meeting

Recce Pharmaceuticals to Present at the ASCPT 2024 Annual Meeting
GLOBENEWSWIRE
13 Mar 2024
Share Share